Search

everythinglearnresearchcommunity

for

Search:↓

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Blocking LFA-1 prevents hair loss in mice.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

An arthritis drug helped a person with severe hair loss regrow their hair.

A new cream, DHMEQ, reduces allergic skin inflammation effectively.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Tofacitinib may effectively treat folliculitis decalvans.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Dupilumab may help treat alopecia areata without needing high IgE levels.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Tofacitinib is effective and safe for treating severe alopecia areata.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Leflunomide is more likely to help treat alopecia areata than cause it.

Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Certain medications can cause serious side effects, so it's important to report them.